$1.08
N/A
At close: Aug 21, 5:00 PM EST
$1.11
0.032.78%
After Hours: Aug 21, 9:26 AM EST
Lineage Cell Therapeutics Inc
LCTXAMEX
Lineage Cell Therapeutics Earnings & Forecasts
Lineage Cell Therapeutics (LCTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Lineage Cell Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.02 | $-0.03 | $-0.05 | $-0.02 |
| Actual | $-0.03 | $-0.03 | $0.00 | $-0.13 |
| Surprise | -50.0% | 0.00% | +108.0% | -550.0% |
| Revenue | ||||
| Estimate | $5.2M | $3.1M | $2.1M | $2.4M |
| Actual | $1.1M | $1.7M | $6.6M | $3.7M |
| Surprise | -79.6% | -44.5% | +214.9% | +51.8% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.03 | $0.01 | $-0.03 | $-0.03 |
| Revenue | ||||
| Consensus | $1.5M | $7.8M | — | — |
